You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健帆生物(300529.SZ):血液透析乾粉取得醫療器械註冊證
格隆匯 03-07 19:41

格隆匯3月7日丨健帆生物(300529.SZ)公佈,公司之控股子公司天津標準於近日收到國家藥品監督管理局頒發的《醫療器械註冊證》,本次取得註冊證的血液透析乾粉是市場新興的枸櫞酸型血液透析乾粉,具有抗凝、調節心血管系統等優勢,且能與公司枸櫞酸型血液透析濃縮液互相補充,更好地滿足不同的市場需求。

本次新取得註冊證的是公司控股子公司天津標準的血液透析乾粉新配方、新產品,該產品使用正常存在於人體內的生理性酸(枸櫞酸)作為pH調節劑,可起到抗凝、調節心血管系統等作用,提高血液透析質量。與血液透析濃縮液相比,血液透析乾粉更便於運輸和儲存,能更好地匹配醫院集中供液系統的使用,滿足不同的治療需求。

至此,公司共有枸櫞酸型透析液/粉、含糖透析液、不同鈣離子濃度透析液等不同品規的血液透析濃縮液/乾粉產品系列,公司血液淨化產品種類進一步得到豐富,能更好地滿足臨牀個體化的治療需求,符合公司深耕血液淨化領域的戰略佈局,將對公司未來的經營發展產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account